Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …
Induced protein degradation: an emerging drug discovery paradigm
Small-molecule drug discovery has traditionally focused on occupancy of a binding site that
directly affects protein function, and this approach typically precludes targeting proteins that …
directly affects protein function, and this approach typically precludes targeting proteins that …
HSP90 inhibitors and cancer: Prospects for use in targeted therapies
ZN Li, Y Luo - Oncology reports, 2022 - spandidos-publications.com
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development
Q Wan, D Song, H Li, M He - Signal transduction and targeted therapy, 2020 - nature.com
Stress proteins (SPs) including heat-shock proteins (HSPs), RNA chaperones, and ER
associated stress proteins are molecular chaperones essential for cellular homeostasis. The …
associated stress proteins are molecular chaperones essential for cellular homeostasis. The …
Treatment of HER2-positive breast cancer: current status and future perspectives
CL Arteaga, MX Sliwkowski, CK Osborne… - Nature reviews Clinical …, 2012 - nature.com
The advent of HER2-directed therapies has significantly improved the outlook for patients
with HER2-positive early stage breast cancer. However, a significant proportion of these …
with HER2-positive early stage breast cancer. However, a significant proportion of these …
Old and new approaches to target the Hsp90 chaperone
J Sanchez, TR Carter, MS Cohen… - Current cancer drug …, 2020 - ingentaconnect.com
The 90-kDa heat shock protein (Hsp90) is a molecular chaperone that ensures cellular
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
P Magnaghi, R D'alessio, B Valsasina, N Avanzi… - Nature chemical …, 2013 - nature.com
VCP (also known as p97 or Cdc48p in yeast) is an AAA+ ATPase regulating endoplasmic
reticulum–associated degradation. After high-throughput screening, we developed …
reticulum–associated degradation. After high-throughput screening, we developed …
[HTML][HTML] Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
Hsp90 is an ATP dependent molecular chaperone protein which integrates multiple
oncogenic pathways. As such, Hsp90 inhibition is a promising anti-cancer strategy. Several …
oncogenic pathways. As such, Hsp90 inhibition is a promising anti-cancer strategy. Several …
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
M Broekgaarden, R Weijer, TM van Gulik… - Cancer and Metastasis …, 2015 - Springer
Photodynamic therapy (PDT) has emerged as a promising alternative to conventional
cancer therapies such as surgery, chemotherapy, and radiotherapy. PDT comprises the …
cancer therapies such as surgery, chemotherapy, and radiotherapy. PDT comprises the …
HSP90 inhibitors: current development and potential in cancer therapy
K Sidera, E Patsavoudi - Recent patents on anti-cancer drug …, 2014 - ingentaconnect.com
In the last decade, the molecular chaperone HSP90 has emerged as an important target in
cancer therapeutics and has subsequently become the focus of several drug discovery and …
cancer therapeutics and has subsequently become the focus of several drug discovery and …